Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selection methods for high-producing mammalian cell lines.

Susan M Browne1, Mohamed Al-Rubeai

  • 1School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4, Ireland.

Trends in Biotechnology
|July 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2021
Same author

Cold atmospheric plasma as an interface biotechnology for enhancing surgical implants.

Critical reviews in biotechnology·2021
Same author

Controlling stem cell fate using cold atmospheric plasma.

Stem cell research & therapy·2020
Same author

Recent advances in the implant-based drug delivery in otorhinolaryngology.

Acta biomaterialia·2020
Same author

A multifunctional dexamethasone-delivery implant fabricated using atmospheric plasma and its effects on apoptosis, osteogenesis and inflammation.

Drug delivery and translational research·2020
Same author

Customizable Implant-specific and Tissue-Specific Extracellular Matrix Protein Coatings Fabricated Using Atmospheric Plasma.

Frontiers in bioengineering and biotechnology·2019
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Selecting high-producing mammalian cell lines for biopharmaceutical production is slow. New high-throughput methods like flow cytometry and automated systems are needed for efficient, cost-effective cell line development.

Area of Science:

  • Biotechnology
  • Bioprocess Engineering
  • Cell Line Development

Background:

  • Mammalian cell line selection is a critical but time-consuming bottleneck in biopharmaceutical production.
  • Traditional screening methods exceed six months, limiting the number of clones evaluated.
  • The growing market for therapeutic proteins necessitates faster, more efficient selection processes.

Purpose of the Study:

  • To address the limitations of traditional cell line selection methods.
  • To highlight the need for efficient, cost-effective, and high-throughput solutions.
  • To introduce alternative screening strategies for biopharmaceutical production.

Main Methods:

  • Review of traditional cell line selection techniques.
  • Discussion of limitations in current screening capacities.

Related Experiment Videos

  • Exploration of alternative high-throughput methods.

    • Main Results:

    • Traditional methods are inefficient and time-consuming.
    • High-throughput methods offer significant improvements in speed and efficiency.
    • Flow-cytometric screening and automated systems are promising alternatives.

    Conclusions:

    • There is a critical need for advanced methods in mammalian cell line selection.
    • High-throughput screening technologies are essential for meeting market demands.
    • Implementing flow cytometry and automation can accelerate biopharmaceutical development.